864
Participants
Start Date
July 31, 2004
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
girentuximab
Given IV
placebo
Given IV
Complejo Medico de la Policia Federal Argentina, Buenos Aires
Instituto Alexander Fleming, Cramer
Hospital Zonal General de Agudos, Ranelagh
Centro de Oncologia Rosario, Rosario
Mount Sinai School of Medicine, New York
Our Lady of Mercy Medical Center Comprehensive Cancer Center, The Bronx
AccuMed Research Associates, Garden City
Community Care Physicians, PC at Urological Institute of NENY, Albany
Hudson Valley Urology, PC, Poughkeepsie
Urological Associates of Lancaster, Limited, Lancaster
Helen F. Graham Cancer Center at Christiana Hospital, Newark
Werner-Francis Urology Associates, LLC, Greenbelt
Alliance Urology Specialists - Greensboro, Greensboro
Carolina BioOncology Institute, Huntersville
Winship Cancer Institute of Emory University, Atlanta
Augusta Oncology Associates - Walton Way, Augusta
Atlantic Urological Associates - Daytona Beach, Daytona Beach
Mayo Clinic - Jacksonville, Jacksonville
Southeastern Research Group, Tallahassee
Urology Associates, Nashville
Cleveland Clinic Taussig Cancer Center, Cleveland
University of Cincinnati, Cincinnati
Northeast Indiana Urology, PC, Fort Wayne
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis
Hematology and Oncology Specialists, LLC - Metairie, Metairie
Regional Urology, LLC, Shreveport
Mary Crowley Medical Research Center at Sammons Cancer Center, Dallas
Urology San Antonio, PA - Fredericksburg, San Antonio
Urology Associates of South Texas, PA, McAllen
Nevada Cancer Institute, Las Vegas
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
CCOP - Virginia Mason Research Center, Seattle
Anchorage
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles
North Idaho Urology - Coeur d'Alene, Coeur d'Alene
Holden Comprehensive Cancer Center at University of Iowa, Iowa City
Feist-Weiller Cancer Center at Louisiana State University Health Sciences, Shreveport
Beth Israel Deaconess Medical Center, Boston
Lahey Clinic Medical Center - Burlington, Burlington
Roswell Park Cancer Institute, Buffalo
Riverside Methodist Hospital Cancer Care, Columbus
Vanderbilt-Ingram Cancer Center, Nashville
Vermont Cancer Center at University of Vermont, Burlington
Unidad Oncologica Del Neuquen, Neuquén
Clinical Especializada ISIS, Santa Fe
Biocancer Centro de Pesq e Trat de Cancer SA, Belo Horizonte
Nucleo de Oncologia da Bahia, Bahia
Instituto Nacional de Cancer, Rio de Janeiro
Hospital Sirio-Libanes, São Paulo
Universidade Federal de Sao Paulo, São Paulo
G. Steinhoff Clinical Research, Victoria
McMaster Institute of Urology at St. Joseph Healthcare, Hamilton
Male Health Centre - Oakville, Oakville
CMX Research, Incorporated, Oakville
Male Health Centre - North York, Toronto
Hopital Charles Lemoyne, Greenfield Park
Lead Sponsor
Heidelberg Pharma AG
INDUSTRY